The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Lymphoma, Diffuse

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Lymphoma, Diffuse

 

High impact information on Lymphoma, Diffuse

 

Chemical compound and disease context of Lymphoma, Diffuse

 

Biological context of Lymphoma, Diffuse

 

Anatomical context of Lymphoma, Diffuse

  • Ribosomes prepared from murine lymphosarcoma cells were phosphorylated by a cyclic AMP-independent protein kinase designated H4P kinase [19].
  • Colchicine, nocodazole and vinblastine reduced the number of infiltrating lymphosarcoma cells, probably by interfering with the adhesion of these cells to the exposed hepatocyte surface [20].
  • In this study the potential of immunomodulators was assessed to enhance the specific immune response induced by immunization with reconstituted membranes prepared from SL2 lymphosarcoma cells [21].
  • The purification procedure was applied to a crude thymidylate synthetase preparation from resting E. coli, calf thymus, Sarcoma 180, and Gardner lymphosarcoma [22].
  • The increased osteoclastic bone resorption in hypercalcemic dogs with lymphosarcoma was not mediated by increased circulating levels of immunoreactive parathyroid hormone and 1,25-(OH)2D but was dependent upon infiltration of bone marrow by neoplastic cells and, presumably, the local production of a bone resorption-stimulating factor [23].
 

Gene context of Lymphoma, Diffuse

 

Analytical, diagnostic and therapeutic context of Lymphoma, Diffuse

References

  1. Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Reading, C.L., Brunson, K.W., Torrianni, M., Nicolson, G.L. Proc. Natl. Acad. Sci. U.S.A. (1980) [Pubmed]
  2. Tumor-associated M(r) 34,000 and M(r) 32,000 membrane glycoproteins that are serine phosphorylated specifically in bovine leukemia virus-induced lymphosarcoma cells. Aida, Y., Okada, K., Ohtsuka, M., Amanuma, H. Cancer Res. (1992) [Pubmed]
  3. Carcinogenic potency of alkylating agents in rodents and humans. Dedrick, R.L., Morrison, P.F. Cancer Res. (1992) [Pubmed]
  4. A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. Habeck, L.L., Leitner, T.A., Shackelford, K.A., Gossett, L.S., Schultz, R.M., Andis, S.L., Shih, C., Grindey, G.B., Mendelsohn, L.G. Cancer Res. (1994) [Pubmed]
  5. A novel truncated env gene isolated from a feline leukemia virus-induced thymic lymphosarcoma. Shi, Y., Roy-Burman, P. J. Virol. (2000) [Pubmed]
  6. Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Shen-Ong, G.L., Potter, M., Mushinski, J.F., Lavu, S., Reddy, E.P. Science (1984) [Pubmed]
  7. Selection of a variant lymphoma cell deficient in adenylate cyclase. Bourne, H.R., Coffino, P., Tomkins, G.M. Science (1975) [Pubmed]
  8. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma. Chi, C.W., Ip, M.M. J. Natl. Cancer Inst. (1988) [Pubmed]
  9. Two cases of lymphosarcoma in channel catfish exposed to N-methyl-N'-nitro-N-nitrosoguanidine. Chen, H.H., Brittelli, M.R., Muska, C.F. J. Natl. Cancer Inst. (1985) [Pubmed]
  10. Comparison of the antitumor activity and toxicity of 2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine and 2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine. Zakrzewski, S.F., Dave, C., Rosen, F. J. Natl. Cancer Inst. (1978) [Pubmed]
  11. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice. Thompson, E.A., Moore, W.M., Sawyer, R.H. J. Natl. Cancer Inst. (1980) [Pubmed]
  12. Distribution of anticancer agents in spontaneous animal tumors. II. Distribution of gallium in canine lymphosarcoma. Straw, J.A., Klubes, P., Hart, M.M. J. Natl. Cancer Inst. (1975) [Pubmed]
  13. Collateral sensitivity between methylene dimethane sulfonate and halogenated methotrexate derivatives in the Yoshida sarcoma in vivo and in vitro. Fox, B.W. J. Natl. Cancer Inst. (1977) [Pubmed]
  14. Co-expression of N-ras p21 and C-erbB-2 (neu) oncogene products by common ALL antigen-positive aggressive diffuse lymphoma. Imamura, N., Miyazawa, T., Mtasiwa, D., Kuramoto, A. Lancet (1990) [Pubmed]
  15. Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids. Huang, S., Hershey, J.W. Mol. Cell. Biol. (1989) [Pubmed]
  16. Effects of liposome dose and the presence of lymphosarcoma cells on blood clearance and tissue distribution of large unilamellar liposomes in mice. Ellens, H., Morselt, H.W., Dontje, B.H., Kalicharan, D., Hulstaert, C.E., Scherphof, G.L. Cancer Res. (1983) [Pubmed]
  17. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil. Ghoshal, K., Jacob, S.T. Cancer Res. (1994) [Pubmed]
  18. Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Majumder, S., Ghoshal, K., Li, Z., Bo, Y., Jacob, S.T. Oncogene (1999) [Pubmed]
  19. Phosphorylation of ribosomal protein S6 at multiple sites by a cyclic AMP-independent protein kinase from lymphoid cells. Donahue, M.J., Masaracchia, R.A. J. Biol. Chem. (1984) [Pubmed]
  20. Effect of tubulin-binding agents on the infiltration of tumour cells into primary hepatocyte cultures. Roos, E., Van de Pavert, I.V. J. Cell. Sci. (1982) [Pubmed]
  21. Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens. Bergers, J.J., Den Otter, W., Dullens, H.F., De Groot, J.W., Steerenberg, P.A., Filius, P.M., Crommelin, D.J. Int. J. Cancer (1994) [Pubmed]
  22. Purification of thymidylate synthetase from enzyme-poor sources by affinity chromatography. Slavík, K., Rode, W., Slavíková, V. Biochemistry (1976) [Pubmed]
  23. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations. Meuten, D.J., Kociba, G.J., Capen, C.C., Chew, D.J., Segre, G.V., Levine, L., Tashjian, A.H., Voelkel, E.F., Nagode, L.A. Lab. Invest. (1983) [Pubmed]
  24. Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells. Datta, J., Majumder, S., Bai, S., Ghoshal, K., Kutay, H., Smith, D.S., Crabb, J.W., Jacob, S.T. Cancer Res. (2005) [Pubmed]
  25. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X., Parthun, M., Jacob, S.T. Mol. Cell. Biol. (2002) [Pubmed]
  26. Structural organization and nucleotide sequence of mouse c-myb oncogene: activation in ABPL tumors is due to viral integration in an intron which results in the deletion of the 5' coding sequences. Lavu, S., Reddy, E.P. Nucleic Acids Res. (1986) [Pubmed]
  27. Identification and localization of steroid-binding and nonsteroid-binding forms of the glucocorticoid receptor in the mouse P1798 lymphosarcoma. Rowan, B.G., Ip, M.M. J. Steroid Biochem. Mol. Biol. (1995) [Pubmed]
  28. Stress-induced decline in immune responsiveness in C3H/HeJ mice: relation to endocrine alterations and tumor growth. Kandil, O., Borysenko, M. Brain Behav. Immun. (1988) [Pubmed]
  29. Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants. Conti, P.S., Sordillo, E.M., Sordillo, P.P., Schmall, B. European journal of nuclear medicine. (1985) [Pubmed]
  30. Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy. Hauptmann, G., Petitjean, F., Lang, J.M., Oberling, F. Clin. Exp. Immunol. (1979) [Pubmed]
  31. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Yoshimoto, T., Nishimura, H., Saito, Y., Sakurai, K., Kamisaki, Y., Wada, H., Sako, M., Tsujino, G., Inada, Y. Jpn. J. Cancer Res. (1986) [Pubmed]
 
WikiGenes - Universities